Publication | Closed Access

Malignant Peritoneal Mesothelioma Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Is GLUT1 Expression a Major Prognostic Factor? A Preliminary Study

Cytoreductive SurgerySurgical OncologyGlut1 ExpressionMedicinePathologySurgeryCancer TreatmentOncologyMalignant DiseaseCancer ResearchHyperthermic Intraperitoneal Chemotherapy